Directed new share issue in Weifa ASA (NO) – NOK 115 million

Carnegie acted as joint book-runner in the directed new share issue of 144 million new shares at a subscription price of NOK 0.80 per share. Weifa ASA (formerly Aqualis ASA) has, through the recent acquisition of Weifa AS, become Norway’s leading fully-integrated pharmaceutical company and a major supplier of active ingredients to the international pharmaceutical industry. September 2014.